WEE1 and cancer: It is therefore not surprising that the first described Wee1 inhibitor, (non-selective) PD0166285, was tested in combination with ionizing radiation and was found to radiosensitize, i.e. to kill more efficiently, cancer cells in a p53-dependent manner (83).